Dilemma in classifications of possible precursors of pancreatic cancer involving the main pancreatic duct: PanIN or IPMN?

Journal of Gastroenterology

Volumn 38, Issue 3, 2003, Pages 311-313

  Takaori, Kyoichi ^a  

^a ASAHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 1; MUCIN 2;

CANCER CLASSIFICATION; CARCINOGENESIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPITHELIUM CELL; HUMAN; PANCREAS CANCER; PANCREAS DUCT; PANCREAS DUCT STENOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CONSTRICTION, PATHOLOGIC; DISEASE PROGRESSION; HUMANS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS;

EID: 0038410117     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350300057     Document Type: Editorial

References (14)

1. Klöppel G. Pathology of nonendocrine pancreatic tumors. In: Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Reber HA, Sceele GA, editors. The pancreas. 2nd ed. New York: Raven; 1993. p. 871-97.
2. Longnecker DS. The quest for preneoplastic lesions in the pancreas. Arch Pathol Lab Med 1994;118:226.
3. Klimstra DS, Longnecker DS. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994;145:1547-50.
4. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-86.
5. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000;60:2002-6.
6. Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002;15:1087-95.
7. Luttges J, Zamboni G, Longnecker D, Kloppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-8.
8. Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg 2002; 25:942-8.
9. Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, et al. Intraductal papillary mucinous tumors of the pancreas comprise two clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999;134: 1131-6.
10. Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24:1372-7.
11. Fujikawa T, Matsusue S, Nakamura Y, Takaori K. Role of magnetic resonance cholangiopancreatography in diagnosing pancreatic cancer originating from the peripheral duct. Am J Gastroenterol 2000;95:1378-9.
12. Takaori K, Kobashi Y, Matsusue S, Matsui K, Yamamoto T. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg 2003; in press.
13. Kogire M, Tokuhara K, Itoh D, Koshiba T, Sato M, Yamanaka H, et al. A typical ductal hyperplasia of the pancreas associated with a stricture of the main pancreatic duct. J Gastroenterol 2003; 38:295-7.
14. Takaori K, Matsusue S, Fujikawa T, Kobashi Y, Ito T, Matsuo Y, et al. Carcinoma in situ of the pancreas associated with localized fibrosis: A clue to early detection of neoplastic lesions arising from pancreatic ducts. Pancreas 1998;17:102-5.